Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -13.27M
March 31, 2024 -18.21M
December 31, 2023 -23.91M
September 30, 2023 -35.09M
June 30, 2023 -40.42M
March 31, 2023 -54.91M
December 31, 2022 -61.60M
September 30, 2022 -66.85M
June 30, 2022 -66.29M
March 31, 2022 -54.79M
December 31, 2021 -49.00M
September 30, 2021 -33.98M
June 30, 2021 -27.66M
March 31, 2021 -25.74M
December 31, 2020 -20.91M
September 30, 2020 -22.70M
June 30, 2020 -21.43M
March 31, 2020 -17.79M
December 31, 2019 -19.30M
September 30, 2019 -21.13M
June 30, 2019 -18.76M
March 31, 2019 -15.76M
December 31, 2018 -8.126M
September 30, 2018 -3.682M
June 30, 2018 -6.36M
Date Value
March 31, 2018 -9.687M
December 31, 2017 -10.57M
September 30, 2017 -10.67M
June 30, 2017 -9.759M
March 31, 2017 -9.907M
December 31, 2016 -13.78M
September 30, 2016 -12.49M
June 30, 2016 -16.78M
March 31, 2016 -21.58M
December 31, 2015 -22.64M
September 30, 2015 -30.45M
June 30, 2015 -27.95M
March 31, 2015 -23.97M
December 31, 2014 -18.03M
September 30, 2014 -7.963M
June 30, 2014 -8.224M
March 31, 2014 -9.284M
December 31, 2013 -15.10M
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012 -14.07M
June 30, 2012 -13.97M
March 31, 2012 -12.45M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Filana Therapeutics, Inc. -28.70M
CorMedix, Inc. 253.62M
Eloxx Pharmaceuticals, Inc. --
Cannabis Global, Inc. -0.2899M
BioStem Technologies, Inc. -5.919M